glp-1 drugs and thyroid cancer Increased Risks May Be Product of More Intense Screening, Study Finds Do GLP-1 Medications Cause Thyroid

sudden drops or no change over 8 weeks should prompt a doctor visit

The GLP-1 hormone is rapidly inactivated by the enzyme DPP-4, with a half-life of only 12 min

Additionally, they activate the AMPK pathway in liver cells, which promotes fatty acid oxidation and reduces lipid accumulation (lipogenesis), offering potential benefits for non-alcoholic fatty liver disease (NAFLD) (Zheng et al., 2024)

However, obesity treatment is now the fastest growing application segment

however, this was for diabetes indications and GLP-1s were not included on the EML for obesity

Orforglipron significantly improved those parameters compared with controls